Korian
Market Cap
€3.1b
Last Updated
2019/10/23 21:01 UTC
Data Sources
Company Financials +
Executive Summary
Korian provides integrated health and care services for the elderly in France, Germany, Belgium, Italy, Spain, and the Netherlands.
Snowflake
Fundamentals
Good value with reasonable growth potential and pays a dividend.
Similar Companies
Share Price & News
How has Korian's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
-1.5%
KORI
-3.6%
FR Healthcare
-0.9%
FR Market
1 Year Return
10.7%
KORI
2.9%
FR Healthcare
12.5%
FR Market
Return vs Industry: KORI exceeded the French Healthcare industry which returned 2.9% over the past year.
Return vs Market: KORI exceeded the French Market which returned 12.5% over the past year.
Shareholder returns
| KORI | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.5% | -3.6% | -0.9% |
| 30 Day | 2.9% | -1.4% | -0.8% |
| 90 Day | 9.6% | 0.5% | -0.5% |
| 1 Year | 12.6%10.7% | 5.4%2.9% | 16.3%12.5% |
| 3 Year | 43.8%35.9% | 45.3%39.1% | 43.1%29.1% |
| 5 Year | 48.8%34.7% | 91.5%71.9% | 71.4%45.4% |
Price Volatility Vs. Market
How volatile is Korian's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Can We See Significant Institutional Ownership On The Korian (EPA:KORI) Share Register?3 weeks ago | Simply Wall St
How Korian (EPA:KORI) Could Add Value To Your Portfolio1 month ago | Simply Wall St
These 4 Measures Indicate That Korian (EPA:KORI) Is Using Debt ExtensivelyValuation
Is Korian undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: KORI (€37.92) is trading below our estimate of fair value (€81.47)
Significantly Below Fair Value: KORI is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: KORI is good value based on its PE Ratio (26x) compared to the Healthcare industry average (30.3x).
PE vs Market: KORI is poor value based on its PE Ratio (26x) compared to the French market (17.3x).
Price to Earnings Growth Ratio
PEG Ratio: KORI is poor value based on its PEG Ratio (1.4x)
Price to Book Ratio
PB vs Industry: KORI is good value based on its PB Ratio (1.3x) compared to the FR Healthcare industry average (2.6x).
Next Steps
Future Growth
How is Korian forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
18.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KORI's forecast earnings growth (18.6% per year) is above the savings rate (0.7%).
Earnings vs Market: KORI's earnings (18.6% per year) are forecast to grow faster than the French market (11.4% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: KORI's revenue (5.9% per year) is forecast to grow faster than the French market (4.4% per year).
High Growth Revenue: KORI's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KORI's Return on Equity is forecast to be low in 3 years time (6.4%).
Next Steps
Past Performance
How has Korian performed over the past 5 years?
22.6%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: KORI's earnings have grown significantly by 22.6% per year over the past 5 years.
Accelerating Growth: KORI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: KORI had negative earnings growth (-33.9%) over the past year, making it difficult to compare to the Healthcare industry average (-4.9%).
Return on Equity
High ROE: KORI's Return on Equity (4.9%) is considered low.
Return on Assets
ROA vs Industry: KORI's Return on Assets is below or equal to the Healthcare industry average last year.
Return on Capital Employed
ROCE Improving: KORI has improved its Return on Capital Employed over the past 3 years.
Next Steps
Financial Health
How is Korian's financial position?
Financial Position Analysis
Short Term Liabilities: KORI's short term assets (€895.1M) do not cover its short term liabilities (€1.7B)
Long Term Liabilities: KORI's short term assets (895.1M) do not cover its long term liabilities (6.5B)
Debt to Equity History and Analysis
Debt Level: KORI's debt to equity ratio (111.3%) is considered high
Reducing Debt: KORI's debt to equity ratio has increased from 64% to 111.3% over the past 5 years.
Debt Coverage: KORI's debt is well covered by operating cash flow (21.9%).
Interest Coverage: KORI's interest payments on its debt are well covered by EBIT (4.1x coverage).
Balance Sheet
Inventory Level: KORI has a high level of physical assets or inventory.
Debt Coverage by Assets: KORI's debt is not covered by short term assets (assets are 0.3x debt).
Next Steps
Dividend
What is Korian's current dividend yield, its reliability and sustainability?
1.58%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: KORI's dividend (1.58%) is higher than the bottom 25% of dividend payers in the French market (1.55%).
High Dividend: KORI's dividend (1.58%) is low compared to the top 25% of dividend payers in the French market (4.71%).
Stable Dividend: KORI's dividends per share have been stable in the past 10 years.
Growing Dividend: KORI's dividend payments have not increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (41.1%), KORI's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: KORI's dividends in 3 years are forecast to be well covered by earnings (38.9% payout ratio).
Next Steps
Management
What is the CEO of Korian's salary, the management and board of directors tenure and is there insider trading?
3.1yrs
Average management tenure
CEO
Sophie Boissard (49yo)
3.8yrs
Tenure
€1,002,516
Compensation
Mrs. Sophie Boissard has been the Chief Executive Officer at Korian SA since January 26, 2016. Mrs. Boissard serves as an Executive in Railway Operator SNCF. She serves as Managing Director of SNCF Immobil ...
CEO Compensation Analysis
Compensation vs. Market: Sophie's total compensation ($USD1.12M) is about average for companies of similar size in the French market ($USD1.35M).
Compensation vs Earnings: Sophie's compensation has been consistent with company performance over the past year.
Management Age and Tenure
3.1yrs
Average Tenure
52yo
Average Age
Experienced Management: KORI's management team is considered experienced (3.1 years average tenure).
Board Age and Tenure
5.1yrs
Average Tenure
57.5yo
Average Age
Experienced Board: KORI's board of directors are considered experienced (5.1 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Management Team
Bruno Marie (65yo)
Chairman of the Medidep Management Board
- Tenure: 13.1yrs
Rémi Boyer (52yo)
Group Chief Human Resources & CSR Officer
- Tenure: 3.1yrs
Sophie Boissard (49yo)
Chief Executive Officer
- Tenure: 3.8yrs
- Compensation: €1.00m
Philippe Denormandie
Deputy Chief Executive Officer
- Tenure: 0yrs
- Compensation: €59.22k
Claude Malhuret
Head of Ethical Development Department
- Tenure: 0yrs
Nathalie Lundqvist
Director of Group Strategy
- Tenure: 0yrs
Philippe Garin
Chief Financial Officer
- Tenure: 1.5yrs
Caroline de Jessey
Group Chief Communication Officer
- Tenure: 1.8yrs
Sarah Mingham
Vice President of Investor Relations & Financing
- Tenure: 0yrs
Philippe Lonné
Chief Information Officer
- Tenure: 0yrs
Board Members
Jean-Pierre Duprieu (67yo)
Independent Director
- Tenure: 3.3yrs
- Compensation: €57.81k
Jérôme Grivet (57yo)
Director
- Tenure: 5.6yrs
- Compensation: €26.32k
Guy de Panafieu (76yo)
Board Observer
- Tenure: 2.3yrs
- Compensation: €25.00k
Catherine Soubie (54yo)
Independent Director
- Tenure: 5.6yrs
- Compensation: €64.68k
Anne Lalou (56yo)
Independent Director
- Tenure: 5.6yrs
- Compensation: €46.36k
Françoise Jacqueline Debrus (59yo)
Director
- Tenure: 5.6yrs
- Compensation: €26.61k
Christian Chautard (71yo)
Chairman
- Tenure: 4.6yrs
- Compensation: €345.00k
Jérôme Grivet (57yo)
Director
- Tenure: 5.6yrs
Markus Müschenich (58yo)
Independent Director
- Tenure: 2.3yrs
- Compensation: €56.97k
Hafida Cola (49yo)
Employee Representative Director
- Tenure: 3.8yrs
- Compensation: €11.55k
Company Information
Korian's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Korian
- Ticker: KORI
- Exchange: ENXTPA
- Founded: 2001
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: €3.136b
- Shares outstanding: 82.70m
- Website: https://www.korian.com/fr
Number of Employees
Location
- Korian
- 21-25 rue Balzac
- Paris
- Ile-de-France
- 75008
- France
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| KORI | ENXTPA (Euronext Paris) | Yes | Common Stock | FR | EUR | Nov 2006 |
| KO2 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Nov 2006 |
| 0OPS | LSE (London Stock Exchange) | Yes | Common Stock | GB | EUR | Nov 2006 |
| KORIP | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Common Stock | GB | EUR | Nov 2006 |
Biography
Korian provides integrated health and care services for the elderly in France, Germany, Belgium, Italy, Spain, and the Netherlands. The company operates long-term care nursing homes, specialized clinics, a ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/23 21:01 |
| End of Day Share Price | 2019/10/23 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.